 Connection
Michael Bristow to Antibodies, Monoclonal
This is a "connection" page, showing publications Michael Bristow has written about Antibodies, Monoclonal.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.564 |
|
|
|
-
O'Connell JB, Renlund DG, Hammond EH, Wittwer CT, Yowell RL, DeWitt CW, Jones KW, Gay WA, Menlove RL, Bristow MR. Sensitization to OKT3 monoclonal antibody in heart transplantation: correlation with early allograft loss. J Heart Lung Transplant. 1991 Mar-Apr; 10(2):217-21; discussion 221-2.
Score: 0.056
-
Hegewald MG, O'Connell JB, Renlund DG, Lee HR, Burton NA, Karwande SV, Jones KW, Lassetter JE, Bristow MR. OKT3 monoclonal antibody given for ten versus fourteen days as immunosuppressive prophylaxis in heart transplantation. J Heart Transplant. 1989 Jul-Aug; 8(4):303-9; discussion 309-10.
Score: 0.050
-
O'Connell JB, Renlund DG, Gay WA, DeWitt CW, Hammond EH, Yowell RL, Jones KW, Karwande SV, Doty DB, Bristow MR. Efficacy of OKT3 retreatment for refractory cardiac allograft rejection. Transplantation. 1989 May; 47(5):788-92.
Score: 0.049
-
Renlund DG, O'Connell JB, Bristow MR. Early rejection prophylaxis in heart transplantation: is cytolytic therapy necessary? J Heart Transplant. 1989 May-Jun; 8(3):191-3.
Score: 0.049
-
Gay WA, O'Connell JG, Burton NA, Karwande SV, Renlund DG, Bristow MR. OKT3 monoclonal antibody in cardiac transplantation. Experience with 102 patients. Ann Surg. 1988 Sep; 208(3):287-90.
Score: 0.047
-
Gilbert EM, O'Connell JB, Hammond ME, Renlund DG, Watson FS, Bristow MR. Treatment of myocarditis with OKT3 monoclonal antibody. Lancet. 1988 Apr 02; 1(8588):759.
Score: 0.046
-
Bristow MR, Gilbert EM, O'Connell JB, Renlund DG, Watson FS, Hammond E, Lee RG, Menlove R. OKT3 monoclonal antibody in heart transplantation. Am J Kidney Dis. 1988 Feb; 11(2):135-40.
Score: 0.045
-
Gilbert EM, Eiswirth CC, Renlund DG, Menlove RL, DeWitt CW, Freedman LA, Herrick CM, Gay WA, Bristow MR. Use of Orthoclone OKT3 monoclonal antibody in cardiac transplantation: early experience with rejection prophylaxis and treatment of refractory rejection. Transplant Proc. 1987 Apr; 19(2 Suppl 1):45-53.
Score: 0.043
-
Gilbert EM, Dewitt CW, Eiswirth CC, Renlund DG, Menlove RL, Freedman LA, Herrick CM, Gay WA, Bristow MR. Treatment of refractory cardiac allograft rejection with OKT3 monoclonal antibody. Am J Med. 1987 Feb; 82(2):202-6.
Score: 0.042
-
Ma H, Hammond EH, Taylor DO, Yowell RL, Bristow MR, O'Connell JB, Renlund DG. The repetitive histologic pattern of vascular cardiac allograft rejection. Increased incidence associated with longer exposure to prophylactic murine monoclonal anti-CD3 antibody (OKT3). Transplantation. 1996 Jul 27; 62(2):205-10.
Score: 0.020
-
Moore CK, O'Connell JB, Renlund DG, Bristow MR, Hammond EH. Cardiac allograft cellular rejection during OKT3 prophylaxis in the absence of sensitization. Transplant Proc. 1991 Feb; 23(1 Pt 2):1055-8.
Score: 0.014
-
O'Connell JB, Bristow MR, Hammond EH, Menlove RL, Ensley RD, Ratkovec RM, Renlund DG. Antimurine antibody to OKT3 in cardiac transplantation: implications for prophylaxis and retreatment of rejection. Transplant Proc. 1991 Feb; 23(1 Pt 2):1157-9.
Score: 0.014
-
O'Connell JB, Bristow MR, Rasmussen LG, Ratkovec RM, Gay WA, Jones KW, Renlund DG. Cardiac allograft function with corticosteroid-free maintenance immunosuppression. Circulation. 1990 Nov; 82(5 Suppl):IV318-21.
Score: 0.014
-
Hammond EH, Wittwer CT, Greenwood J, Knape WA, Yowell RL, Menlove RL, Craven C, Renlund DG, Bristow MR, DeWitt CW, et al. Relationship of OKT3 sensitization and vascular rejection in cardiac transplant patients receiving OKT3 rejection prophylaxis. Transplantation. 1990 Nov; 50(5):776-82.
Score: 0.014
-
Hammond EH, Watson FS, Bristow MR, O'Connell JB, Gilbert EM, Doty DB, Renlund DG. Fibrinoid necrosis of a temporal artery complicating the treatment of refractory cardiac allograft rejection with murine monoclonal CD3 antibody (OKT3). J Heart Transplant. 1990 May-Jun; 9(3 Pt 1):236-8.
Score: 0.013
-
Renlund DG, O'Connell JB, Bristow MR. Strategies of immunosuppression in cardiac transplantation. Semin Thorac Cardiovasc Surg. 1990 Apr; 2(2):181-8.
Score: 0.013
-
Wittwer CT, Knape WA, Bristow MR, Gilbert EM, Renlund DG, O'Connell JB, DeWitt CW. The quantitative flow cytometric plasma OKT3 assay. Its potential application in cardiac transplantation. Transplantation. 1989 Sep; 48(3):533-5.
Score: 0.013
-
Wittwer CT, Bristow MR, Gilbert EM, Renlund DG, O'Connell JB, DeWitt CW. OKT3 therapy as a cause of high panel-reactive antibodies in serum using standard microcytotoxicity techniques. Transplantation. 1988 Apr; 45(4):832-4.
Score: 0.011
-
Gilbert EM, Renlund DG, O'Connell JB, Eiswirth CC, Rothstein G, Gay WA, Bristow MR. Immunosuppressive efficacy of vincristine in heart transplantation: a preliminary report. J Heart Transplant. 1987 Nov-Dec; 6(6):369-74.
Score: 0.011
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|